Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 26, 2022
Accession Number: 0001193125-22-111227
Submission Type: POS AM
CIK: 0001833214
Company Name: SAB Biotherapeutics, Inc.
File Number: 333-261496